Federal Circuit Invalidates Diagnostic Method Claims for Prenatal Test Under 35 U.S.C. 101
Categories: Dispute Resolution
On June 12, 2015, the Federal Circuit’s decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc. affirmed the finding of U.S. District Court for the Northern District of California that the method claims in U.S.